Industries > Pharma > Female Health Tech Market Report 2024-2034
Female Health Tech Market Report 2024-2034
Forecasts by Product Types (Consumer Products, Devices (Wearables, Hardware), Software (Apps), Diagnostics, Digital Platforms, Drugs, Vitamins & Supplements, Services, Telehealth), by Application (Pregnancy and Nursing Care, Reproductive Health and Contraception, Menstrual Health, General Healthcare, Pelvic and Uterine Healthcare, Sexual Health, Women’s Wellness, Menopause Care, Longevity, Mental Health) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Female Health Tech Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increased Awareness and Focus on Women’s Health
Increased awareness and focus on women’s health have been transformative, driven by a confluence of factors that have brought long-overdue attention to the unique healthcare needs of women. Historically, women’s health issues were often overlooked or generalized within the broader context of healthcare. However, concerted efforts from healthcare professionals, researchers, advocacy groups, and policymakers have reshaped this landscape. Research initiatives have delved into conditions specific to women, unravelling the complexities of reproductive health, hormonal fluctuations, and diseases like endometriosis and polycystic ovary syndrome (PCOS). Simultaneously, educational campaigns have sought to dismantle taboos surrounding women’s health, fostering open dialogues and empowering women to advocate for their own well-being. Public health campaigns have spotlighted critical issues such as maternal mortality rates, breast cancer awareness, and access to contraception, amplifying the urgency for targeted interventions. Moreover, advocacy movements have catalyzed policy changes, leading to greater recognition of women’s health as a fundamental aspect of public health agendas. This heightened awareness has not only fostered a more inclusive approach to healthcare but has also driven innovation in female health technology, with solutions ranging from wearable devices for menstrual tracking to AI-powered platforms for personalized health insights. Overall, the increased awareness and focus on women’s health signify a pivotal shift towards equitable healthcare provision and a deeper understanding of the diverse needs of women across the lifespan.
Technological advancements in patient care
Technological advancements in female health tech have revolutionized the landscape of women’s healthcare, offering innovative solutions tailored to address the unique needs and experiences of women. These advancements span a wide range of areas, from reproductive health to menopause management, and have been made possible by breakthroughs in various fields of technology.
Wearable devices, such as smartwatches and fitness trackers, have emerged as powerful tools for women to monitor their menstrual cycles, track fertility windows, and manage overall health and wellness. These devices leverage sensors and algorithms to collect data on physiological parameters, providing users with valuable insights into their reproductive health and helping them make informed decisions about contraception, fertility planning, and menstrual cycle management.
Mobile applications have also played a crucial role in empowering women to take control of their health. These apps offer a diverse array of features, including menstrual tracking, ovulation prediction, pregnancy monitoring, and symptom management for conditions like endometriosis and PCOS. By digitizing health information and providing personalized recommendations, these apps enable women to actively participate in managing their health and well-being.
Telemedicine platforms have expanded access to healthcare services for women, particularly in underserved areas or for individuals with mobility constraints. These platforms facilitate remote consultations with healthcare providers, enabling women to seek advice, receive diagnoses, and access treatments from the comfort of their homes. This has proven especially valuable during the COVID-19 pandemic, when in-person healthcare services were limited.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Female Health Tech Market evolving?
- What is driving and restraining the Female Health Tech Market?
- How will each Female Health Tech submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Female Health Tech submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading Female Health Tech Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Female Health Tech projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of Female Health
- Tech projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Female Health Tech Market?
- Where is the Female Health Tech Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Female Health Tech Market today, and over the next 10 years:
- Our 284-page report provides 101 tables and 130 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Female Health Tech Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Female Health Tech prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product Types
- Consumer Products
- Devices (Wearables, Hardware)
- Software (Apps)
- Diagnostics
- Digital Platform
- Drugs, Vitamins & Supplements
- Services
- Telehealth
By Application
- Pregnancy and Nursing Care
- Reproductive Health and Contraception
- Menstrual Health
- General Healthcare
- Pelvic and Uterine Healthcare
- Sexual Health
- Women’s Wellness
- Menopause Care
- Longevity
- Mental Health
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 25 leading national markets:
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Belgium
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Taiwan
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Female Health Tech Market, 2024 to 2034, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
- Athena Feminine Technologies
- Bloomlife
- Elvie (Chiaro Technology Limited)
- HeraMED
- iSono Health
- Minerva Surgical
- NUVO Inc
- Prelude Fertility, Inc.
- Sera Prognostics
- Univfy Inc.
- TOTOHEALTH LIMITED
Overall world revenue for Female Health Tech Market, 2024 to 2034 in terms of value the market will surpass US$ 140.9 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Female Health Tech Market, 2024 to 2034 report help you?
In summary, our 280+ page report provides you with the following knowledge:
- Revenue forecasts to 2034 for Female Health Tech Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 27 key national markets – See forecasts for the Female Health Tech Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 11 of the major companies involved in the Female Health Tech Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Female Health Tech Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Female Health Tech Market Report 2024-2034: Forecasts by Product Types (Consumer Products, Devices (Wearables, Hardware), Software (Apps), Diagnostics, Digital Platforms, Drugs, Vitamins & Supplements, Services, Telehealth), by Application (Pregnancy and Nursing Care, Reproductive Health and Contraception, Menstrual Health, General Healthcare, Pelvic and Uterine Healthcare, Sexual Health, Women’s Wellness, Menopause Care, Longevity, Mental Health) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1.1 Objectives of the Study
1.2 Introduction to Female Health Tech Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Awareness and Education
3.2.1.2 Rapid Advancements in Technology are Catalysing the Growth of the Female Health Tech Market
3.2.1.3 Increasing Empowerment and Advocacy for Women's Health and Wellness
3.2.1.4 Healthcare Personalization is a Key Driving Force Behind the Growth of the Female Health Tech
3.2.2 Market Restraining Factors
3.2.2.1 Complex Regulatory Frameworks and Varying Standards for Healthcare Technologies Across Different Region
3.2.2.2 Privacy and Security Risks Associated with the Collection, Storage, and Transmission of Sensitive Health Data
3.2.2.3 Healthcare Inequities and Disparities in Access to Healthcare Services, Particularly in Underserved Regions and Marginalized Communities
3.2.3 Market Opportunities
3.2.3.1 Development of New Products and Services that Address Unmet Needs in Women's Health
3.2.3.2 Partnerships Between Healthcare Providers, Technology Companies, and Research Institutions
3.2.3.3 Global Health Initiatives Aimed at Improving Women's Health Outcomes
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Female Health Tech Market Analysis by Product Type
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Female Health Tech Market Size Estimation and Forecast by Product Types
4.4 Consumer Products
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Devices (Wearables, hardware)
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Software (Apps)
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Diagnostics
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Digital Platform
4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Drugs, Vitamins & Supplements
4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Services
4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
4.10.2 Market Share by Region, 2024 & 2034 (%)
4.11 Telehealth
4.11.1 Market Size by Region, 2024-2034 (US$ Billion)
4.11.2 Market Share by Region, 2024 & 2034 (%)
5 Female Health Tech Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Female Health Tech Market Size Estimation and Forecast by Application
5.4 Pregnancy and Nursing Care
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Reproductive Health and Contraception
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Menstrual Health
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 General Healthcare
5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Pelvic and Uterine Healthcare
5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Sexual Health
5.9.1 Market Size by Region, 2024-2034 (US$ Billion)
5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Women’s Wellness
5.10.1 Market Size by Region, 2024-2034 (US$ Billion)
5.10.2 Market Share by Region, 2024 & 2034 (%)
5.11 Menopause Care
5.11.1 Market Size by Region, 2024-2034 (US$ Billion)
5.11.2 Market Share by Region, 2024 & 2034 (%)
5.12 Longevity
5.12.1 Market Size by Region, 2024-2034 (US$ Billion)
5.12.2 Market Share by Region, 2024 & 2034 (%)
5.13 Mental Health
5.13.1 Market Size by Region, 2024-2034 (US$ Billion)
5.13.2 Market Share by Region, 2024 & 2034 (%)
6 Female Health Tech Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Female Health Tech Market Analysis
7.1 Key Findings
7.2 North America Female Health Tech Market Attractiveness Index
7.3 North America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
7.4 North America Female Health Tech Market Size Estimation and Forecast by Country
7.5 North America Female Health Tech Market Size Estimation and Forecast by Product Type
7.6 North America Female Health Tech Market Size Estimation and Forecast by Application
7.7 U.S. Female Health Tech Market Analysis
7.8 Canada Female Health Tech Market Analysis
8 Europe Female Health Tech Market Analysis
8.1 Key Findings
8.2 Europe Female Health Tech Market Attractiveness Index
8.3 Europe Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 Europe Female Health Tech Market Size Estimation and Forecast by Country
8.5 Europe Female Health Tech Market Size Estimation and Forecast by Product Type
8.6 Europe Female Health Tech Market Size Estimation and Forecast by Application
8.7 Germany Female Health Tech Market Analysis
8.8 France Female Health Tech Market Analysis
8.9 UK Female Health Tech Market Analysis
8.10 Italy Female Health Tech Market Analysis
8.11 Spain Female Health Tech Market Analysis
8.12 Russia Female Health Tech Market Analysis
8.13 Poland Female Health Tech Market Analysis
8.14 Belgium Female Health Tech Market Analysis
8.15 Rest of Europe Female Health Tech Market Analysis
9 Asia Pacific Female Health Tech Market Analysis
9.1 Key Findings
9.2 Asia Pacific Female Health Tech Market Attractiveness Index
9.3 Asia Pacific Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Country
9.5 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Product Type
9.6 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Application
9.7 Japan Female Health Tech Market Analysis
9.8 China Female Health Tech Market Analysis
9.9 India Female Health Tech Market Analysis
9.10 Australia Female Health Tech Market Analysis
9.11 South Korea Female Health Tech Market Analysis
9.12 Singapore Female Health Tech Market Analysis
9.13 Taiwan Female Health Tech Market Analysis
9.14 Rest of Asia Pacific Female Health Tech Market Analysis
10 Latin America Female Health Tech Market Analysis
10.1 Key Findings
10.2 Latin America Female Health Tech Market Attractiveness Index
10.3 Latin America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Latin America Female Health Tech Market Size Estimation and Forecast by Country
10.5 Latin America Female Health Tech Market Size Estimation and Forecast by Product Type
10.6 Latin America Female Health Tech Market Size Estimation and Forecast by Application
10.7 Brazil Female Health Tech Market Analysis
10.8 Mexico Female Health Tech Market Analysis
10.9 Argentina Female Health Tech Market Analysis
10.10 Colombia Female Health Tech Market Analysis
10.11 Rest of Latin America Female Health Tech Market Analysis
11 MEA Female Health Tech Market Analysis
11.1 Key Findings
11.2 MEA Female Health Tech Market Attractiveness Index
11.3 MEA Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 MEA Female Health Tech Market Size Estimation and Forecast by Country
11.5 MEA Female Health Tech Market Size Estimation and Forecast by Product Type
11.6 MEA Female Health Tech Market Size Estimation and Forecast by Application
11.7 GCC Female Health Tech Market Analysis
11.8 South Africa Female Health Tech Market Analysis
11.9 Rest of MEA Female Health Tech Market Analysis
12 Company Profiles
12.1 Competitive Landscape, 2022
12.2 Summary of all Strategic Outlook
12.3 Athena Feminine Technologies, Inc.
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Product Benchmarking
12.3.4 Strategic Outlook
12.4 Bloomlife, Inc.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Product Benchmarking
12.4.4 Strategic Outlook
12.5 Elvie (Chiaro Technology Limited)
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Product Benchmarking
12.5.4 Strategic Outlook
12.6 HeraMed Ltd
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2018-2022
12.6.3.2 R&D, 2017-2022
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 iSono Health, Inc.
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Product Benchmarking
12.7.4 Strategic Outlook
12.8 Minerva Surgical, Inc.
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2020-2022
12.8.3.2 R&D, 2020-2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Nuvo, Inc.
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Product Benchmarking
12.9.4 Strategic Outlook
12.10 Prelude Fertility, Inc.
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Product Benchmarking
12.10.4 Strategic Outlook
12.11 Sera Prognostics
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Univfy, Inc.
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Totohealth Limited
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
List of Tables
Table 1 Female Health Tech Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 7 Consumer Products Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 18 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Women’s Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 28 North America Female Health Tech Market Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 30 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 32 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 39 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 47 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 50 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 51 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 58 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 59 Mexico Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Argentina Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Colombia Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 66 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 69 Strategic Outlook
Table 70 Athena Feminine Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Athena Feminine Technologies, Inc.: Product Benchmarking
Table 72 Athena Feminine Technologies, Inc.: Strategic Outlook
Table 73 Bloomlife, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Bloomlife, Inc.: Product Benchmarking
Table 75 Bloomlife, Inc.: Strategic Outlook
Table 76 Elvie (Chiaro Technology Limited) : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Elvie (Chiaro Technology Limited): Product Benchmarking
Table 78 Elvie (Chiaro Technology Limited): Strategic Outlook
Table 79 HeraMed Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 HeraMed Ltd: Product Benchmarking
Table 81 HeraMed Ltd.: Strategic Outlook
Table 82 iSono Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 iSono Health, Inc.: Product Benchmarking
Table 84 iSono Health, Inc.: Strategic Outlook
Table 85 Minerva Surgical, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Minerva Surgical, Inc.: Product Benchmarking
Table 87 Minerva Surgical, Inc.: Strategic Outlook
Table 88 Nuvo, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Nuvo, Inc.: Product Benchmarking
Table 90 Nuvo, Inc.: Strategic Outlook
Table 91 Prelude Fertility, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Prelude Fertility, Inc.: Product Benchmarking
Table 93 Prelude Fertility, Inc.: Strategic Outlook
Table 94 Sera Prognostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Sera Prognostics: Product Benchmarking
Table 96 Sera Prognostics: Strategic Outlook
Table 97 Univfy, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Univfy Inc.: Product Benchmarking
Table 99 Univfy Inc.: Strategic Outlook
Table 100 Totohealth Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Totohealth Limited.: Product Benchmarking
List of Figures
Figure 1 Female Health Tech Market Segmentation
Figure 2 Female Health Tech Market by Product: Market Attractiveness Index
Figure 3 Female Health Tech Market by Application: Market Attractiveness Index
Figure 4 Female Health Tech Market Attractiveness Index by Region
Figure 5 Female Health Tech Market: Market Dynamics
Figure 6 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Female Health Tech Market: Porter’s Five Forces Analysis
Figure 11 Female Health Tech Market: PEST Analysis
Figure 12 Female Health Tech Market by Product Types: Market Attractiveness Index
Figure 13 Female Health Tech Market Forecast by Product Types, 2024-2034 (US$ Billion, AGR %)
Figure 14 Female Health Tech Market Share Forecast by Product Types, 2024, 2029, 2034 (%)
Figure 15 Consumer Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 16 Consumer Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Devices (Wearables, hardware) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Software (Apps) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Diagnostics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Digital Platform Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Drugs, Vitamins & Supplements Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Services Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Telehealth Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Female Health Tech Market by Application: Market Attractiveness Index
Figure 32 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 33 Female Health Tech Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 34 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Pregnancy and Nursing Care Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Reproductive Health and Contraception Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 39 Menstrual Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 41 General Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 43 Pelvic and Uterine Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Sexual Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Women’s Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Women’s Wellness Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Menopause Care Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Longevity Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Mental Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Female Health Tech Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 55 Female Health Tech Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 56 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 North America Female Health Tech Market Attractiveness Index
Figure 58 North America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 59 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 60 North America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 61 North America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 62 North America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
Figure 63 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 64 North America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 65 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 66 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 67 Europe Female Health Tech Market Attractiveness Index
Figure 68 Europe Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 69 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 70 Europe Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 71 Europe Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 72 Europe Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 73 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 74 Europe Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 75 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 76 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 77 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 78 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 79 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 80 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 81 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 82 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 83 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 Asia Pacific Female Health Tech Market Attractiveness Index
Figure 85 Asia Pacific Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 86 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 87 Asia Pacific Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 88 Asia Pacific Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 89 Asia Pacific Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 90 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 91 Asia Pacific Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 92 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 93 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 94 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 95 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 96 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 97 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 98 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 99 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 100 Latin America Female Health Tech Market Attractiveness Index
Figure 101 Latin America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 102 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 103 Latin America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 104 Latin America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 105 Latin America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
Figure 106 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 108 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Mexico Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Argentina Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Colombia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 MEA Female Health Tech Market Attractiveness Index
Figure 114 MEA Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 115 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 116 MEA Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 117 MEA Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 118 MEA Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 119 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 120 MEA Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 121 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 122 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 Female Health Tech Company Share, 2022
Figure 125 HeraMed Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 126 HeraMed Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 127 Minerva Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 128 Minerva Surgical, Inc.: R&D, 2020-2022 (US$ Million, AGR%)
Figure 129 Sera Prognostics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 130 Sera Prognostics: R&D, 2017-2022 (US$ Million, AGR%)
Athena Feminine Technologies
Bloomlife
Elvie (Chiaro Technology Limited)
HeraMED
iSono Health
Minerva Surgical
NUVO Inc
Prelude Fertility, Inc.
Sera Prognostics
Univfy Inc.
TOTOHEALTH LIMITED
List of Other Companies Mentioned in the Report
Aegis Ventures
Alife
Allbodies
Apple
Apricity
Aroo
Arva Health
Asieris Pharmaceuticals
Aster
Ava Announces
Bellabeat
Biorithm
Blueheart
Bomcomes
Chil
Cispoly
COSM
Diana Health
Dr. Reddy's
Eli
Elvie
Embr Labs
EVE Medical
Evernow
Evvy
FemTec Health
Fertility
Gennev
Google Ventures
Herself Health
Invitae Corp.
Johnson & Johnson Innovation
Kai Health
Kasha’s
Kegelbell
kegg
LG CNS AI
Marma
Maven Clinic
Midi Health
MiMARK Diagnostics
Movano health
Naytal
Northwell Holdings
Organon
OSRAM
Pandia Health
Pharmavite
Plenna
Smile Labs
Solera health
Talkspace
Twentyeight Health
Twig Fertility
Uqora
Wellster
Womaness
List of Associations Mentioned in the Report
Bill & Melinda Gates Foundation
Brazil’s Ministry of Health and Foundation
European Union
Femtech Canada
Health Innovation Network
Lyrebird Health
Medical Technology Association of Australia (MTAA)
U.S. Food Drug Administration
World Health Organisation (WHO)
Download sample pages
Complete the form below to download your free sample pages for Female Health Tech Market Report 2024-2034
Related reports
-
OTC Drugs & Dietary Supplements Market Report 2024-2034
The global OTC Drugs & Dietary Supplements market is projected to grow at a CAGR of 6.7% by 2034...Full DetailsPublished: 11 December 2023 -
Menopause Market Report 2023-2033
The global Menopause market is projected to grow at a CAGR of 5.4% by 2033...Full DetailsPublished: 19 May 2023 -
Women’s Health Market Report 2024-2034
The global Women’s Health market is estimated to grow at a CAGR of 4.6% by 2034...Full DetailsPublished: 18 March 2024 -
Companion Diagnostics (CDx) Market Report 2024-2034
The global Companion Diagnostics (CDx) market is projected to grow at a CAGR of 11% by 2034...Full DetailsPublished: 26 January 2024
Download sample pages
Complete the form below to download your free sample pages for Female Health Tech Market Report 2024-2034
Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Press Release: Peripheral Vascular Device Market Report 2024-2034
The global Peripheral Vascular Devices market is estimated at US$12.49 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
30 April 2024
Press Release: Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024